跳至主要内容
临床试验/NCT05401006
NCT05401006Unknown4 期

Evaluation of the Effect of Acitretin Versus Narrowband Ultraviolet B on Serum Neopterin Level in Psoriatic Patients .

South Valley University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年6月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
30
试验地点
1
主要终点
Serum Neopterin in psoriasis

研究概览

简要总结

To evaluate effect of acitretin versus Narrowband UVB on serum level of neopterin in psoriatic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
15 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with psoriasis diagnosed clinically Aged (15-60).

排除标准

  • Patient with history of skin cancer.
  • Patient with history of photosensitivity.
  • Pregnancy and lactation.
  • Liver failure.
  • Renal failure.
  • Patient with psoriatic artheritis.
  • Patient with allergy to product or any of its components.
  • Patient with poorly controlled dyslipidemia.
  • Patient receiving tetracyclines.

研究组 & 干预措施

Acitretin

Active Comparator

Patients will Receive Acitretin (0.25-1 mg /kg/day )for 3months .

干预措施: Acitretin 25Mg Cap (Drug)

Narrowband ultraviolet B

Active Comparator

Patients will receive Narrowband UVB( 3session /week ) for 3months.

干预措施: Narrowband ultraviolet B (Radiation)

Combination of Narrowband ultraviolet B and Acitretin

Active Comparator

Patients will receive Acitretin (0.25-1 mg /kg/day ) and Narrowband UVB( 3session /week ) for 3 months.

干预措施: Acitretin 25Mg Cap (Drug)

Combination of Narrowband ultraviolet B and Acitretin

Active Comparator

Patients will receive Acitretin (0.25-1 mg /kg/day ) and Narrowband UVB( 3session /week ) for 3 months.

干预措施: Narrowband ultraviolet B (Radiation)

结局指标

主要结局

Serum Neopterin in psoriasis

时间窗: 3 Months

Measurement of Neopterin in psoriatic patients before and after treatment with NB-UVB, Acitretin and combination of both modalities using ELISA (enzyme-linked immunosorbent assay).

次要结局

  • Treatment of psoriasis(3 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fatma Elsayed abd Elfatah Elsayed

Resident doctor

South Valley University

研究点 (1)

Loading locations...

相似试验